Christopher Perrone, MD
Assistant Professor of Clinical Neurology
Associate Clerkship Director, Perelman School of Medicine
Neurology Outpatient Epic Governance Chair, University of Pennsylvania
Department: Neurology
Contact information
3400 Spruce Street, 3 W. Gates Building
Philadelphia, PA 19104
Philadelphia, PA 19104
Office: 215-662-3606
Education:
B.S. (Biology and Psychology)
Tufts University, Medford, MA, 2010.
M.D.
University of Massachusetts Medical School, Worcester, MA, 2014.
B.S. (Biology and Psychology)
Tufts University, Medford, MA, 2010.
M.D.
University of Massachusetts Medical School, Worcester, MA, 2014.
Post-Graduate Training
Internal Medicine Residency Program, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA , 2014-2015.
PGY 2-4, Neurology Residency Program, University of Pennsylvania Health System, Philadelphia, PA , 2015-2018.
PGY 5, Clinical Neuroimmunology Fellowship Program, University of Pennsylvania Health System, Philadelphia, PA , 2018-2019.
Internal Medicine Residency Program, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA , 2014-2015.
PGY 2-4, Neurology Residency Program, University of Pennsylvania Health System, Philadelphia, PA , 2015-2018.
PGY 5, Clinical Neuroimmunology Fellowship Program, University of Pennsylvania Health System, Philadelphia, PA , 2018-2019.
Certifications
American Board of Psychiatry and Neurology, 2018.
Permanent linkAmerican Board of Psychiatry and Neurology, 2018.
Selected Publications
Martin ML, Robert-Fitzgerald T, Schindler MK, Perrone C, Schultz G, Lynch S, Mirkovic N, Thomas S, Elahi A, Reid D, Moore TM, Baller EB, Satterthwaite TD, Cieslak M, Covitz S, Adebimpe A, Manning A, Markowitz CE, Detre JA, Bar-Or A, Kakara M, Shinohara RT.: Impact of insurance status on MRI phenotypes in MS. Mult Scler Relat Disord 92(105919), December 2024.Oh J, Smolders J, Buijs F, Meyer zu Hörste G, Perrone C, van den Brand J, Federer-Gsponer J, Pedotti R, Kaczmarek L, Sharma V, Heinzmann D, Tackenberg B, Bar-Or A, Wiendl H: Defining PIRA and Lack of Disease Stability in the Real-World: Interim Results. European Committee for Treatment and Research in Multiple Sclerosis November 2024 Notes: Poster presentation; presented by co-author.
Baller EB, Sweeney EM, Cieslak MC, Robert-Fitzgerald T, Covitz SC, Martin ML, Schindler MK, Bar-Or A, Elahi A, Larsen BS, Manning AR, Markowitz CE, Perrone CM, Rautman V, Seitz MM, Detre JA, Fox MD, Shinohara RT, Satterthwaite TD: Mapping the relationship of white matter lesions to depression in multiple sclerosis. Biol Psychiatry 95(12): 1072-1080, June 2024 Notes: doi: 10.1016/j.biopsych.2023.11.010.
Son JY, Hu C, McAlpine L, Bar-Or A, Dahl M, Brito SF, Kavak K, Onomichi K, Perrone C, Riley C, Song E, Walker E, Weinstock-Guttmen B, De Jager P, Longbrake E, Xia Z: Post-COVID conditions in people with multiple sclerosis: A cross-sectional multicenter study. American Academy of Neurology April 2024 Notes: Poster presentation; presented by co-author.
Riley C, Venkatesh S, Dhand A, Doshi N, Kavak K, Levit E, Perrone C, Weinstock-Guttman B, Longbrake E, MSReCOV investigators, De Jager P, Xia Z: Impact of the COVID-19 pandemic on personal networks and neurological outcomes of people with multiple sclerosis: A case-control cross-sectional and longitudinal analysis. JMIR Public Health Surveill 10(e45429), February 2024.
Thebault S, Yamashita L, Breville G, Espinoza D, McGoldrick T, Woodson Z, Vitone M, Gandelman S, Windle A, Kadri J, Rezk A, Kim Y, Soldan S, Perrone CM, Jacobs D, Markowitz C, Jefferson A, Schindler M, Bar-Or A: Tandem CSF and blood flow-cytometric immune-cell profiling in the evaluation of neuroinflammatory conditions. Americas Committee for Treatment and Research in Multiple Sclerosis February 2024 Notes: Poster presentation; presented by co-author.
Kim E, Lane C, McCabe K, Gandelman S, Rivera-Torres N, Kakara M, Brandstadter R, Perrone C, Schindler M, Orthmann-Murphy J, Markowitz C, Berger J, Bar-Or A, Perrone E, Noon A, Johnson D, Carmolingo A, Fuller R, Lenzi K, Lee J, Mozes J, Leibowitz L, Pileggi C, Garabedian M, Zeccardi S, Sekella N, Samudralwar R, Stein L, Price R, Jacobs D: Penn multiple sclerosis and related disorders center’s approach towards addressing disparities in care in resident clinic. American Neurological Association September 2023 Notes: Poster presentation; presented by co-author.
Baller E, Sweeney E, Bar-Or A, Cieslak M, Covitz S, Detre J, Elahi A, Manning A, Markowitz C, Martin M, Perrone C, Rautman V, Robert-Fitzgerald T, Schindler M, Siddiqi S, Thomas S, Fox M, Shinohara R, Satterthwaite T: Depression as a disease of white matter network disruption: Characterizing the relationship between white matter lesions and depression in patients with multiple sclerosis. Biol Psychiatry. Elsevier, 93(9): S117, May 2023 Notes: Poster presentation; presented by co-author.
Venkatesh S, Riley C, Dhand A, Doshi N, Kavak K, Levit E, Perrone C, Weinstock-Guttman B, Longbrake E, De Jager P, Xia Z: Impact of the COVID-19 pandemic on personal networks and neurological outcomes of people with multiple sclerosis. American Academy of Neurology. Wolters Kluwer Health, Inc. on behalf of the American Academy of Neurology, 100(17 Supplement 2): P12-3.001, April 2023 Notes: Poster presentation; presented by co-author.
Jakimovski D, Kavak KS, Longbrake EE, Levit E, Perrone CM, Bar-Or A, Benedict RHB, Riley CS, De Jager PL, Venkatesh S, Walker ELS, Xia Z, Weinstock-Guttman B: Impact of resilience, social support, and personality traits in patients with neuroinflammatory diseases during the COVID-19 pandemic. Mult Scler Relat Disord Elsevier, 68: 104235. December 2022.